Yuflyma

adalimumab · Celltrion Healthcare Hungary Kft.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Yuflyma, covering 2026-02-05 to 2026-08-24. Get the full timeline:

Most recent: EMA Authorised: Yuflyma (adalimumab) — Celltrion Healthcare Hungary Kft.